Health Effects of Non-Clinical Psychedelic Use
This summer, I will be continuing my research in conjunction with UC Berkeley, UCSF, and the Global Initiative for Psychedelic Science Economics (GIPSE) to determine the health outcomes that result from psychedelic usage. This project aims to investigate the biomedical and behavioral effects of using MDMA, 2C-B, 2C-I, Ibogaine, Ketamine, and Salvinorin in a non-clinical setting. Through this work, I hope to determine the chronic health impacts of “non-classical,” highly-stigmatized psychedelics and make knowledge around the materials more accessible and transparent. I am fascinated by this subject and am looking forward to spending this summer conducting literature reviews and data extraction on past research.